Quick Answer
IDEXX LABORATORIES INC /DE reported Cash and Equivalents of $180.07 million for fiscal year 2025.
IDEXX LABORATORIES INC /DE Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $180.07M | -37.5% |
| 2024 | $288.27M | -36.5% |
| 2023 | $453.93M | +303.3% |
| 2022 | $112.55M | -22.1% |
| 2021 | $144.45M | -62.4% |
| 2020 | $383.93M | +325.0% |
| 2019 | $90.33M | -27.0% |
| 2018 | $123.79M | -34.0% |
| 2017 | $187.68M | +21.2% |
| 2016 | $154.90M | +20.1% |
| 2015 | $128.99M | -60.0% |
| 2014 | $322.54M | +15.6% |
| 2013 | $279.06M | +24.6% |
| 2012 | $223.99M | +21.8% |
| 2011 | $183.90M | +17.2% |
| 2010 | $156.91M | +47.0% |
| 2009 | $106.73M | +35.3% |
| 2008 | $78.87M | +30.7% |
| 2007 | $60.36M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $208.17M | -32.6% | +26.5% |
| June 30, 2025 | $164.59M | -59.0% | +0.4% |
| March 31, 2025 | $163.97M | -58.7% | -43.1% |
| December 31, 2024 | $288.27M | -36.5% | -6.6% |
| September 30, 2024 | $308.64M | -7.0% | -23.1% |
| June 30, 2024 | $401.59M | +202.3% | +1.0% |
| March 31, 2024 | $397.43M | +256.9% | -12.4% |
| December 31, 2023 | $453.93M | +303.3% | +36.9% |
- IDEXX LABORATORIES INC /DE showed a decrease of -37.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, IDEXX LABORATORIES INC /DE’s cash and equivalents has grown by 198.3% (from $60.36 million to $180.07 million).
- The most recent figure is from IDEXX LABORATORIES INC /DE’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: